These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 22984562)

  • 21. Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
    Zhang T; Choi J; Dilshat R; Einarsdóttir BÓ; Kovacs MA; Xu M; Malasky M; Chowdhury S; Jones K; Bishop DT; Goldstein AM; Iles MM; Landi MT; Law MH; Shi J; Steingrímsson E; Brown KM
    Am J Hum Genet; 2021 Sep; 108(9):1631-1646. PubMed ID: 34293285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation status of the SOCS3 gene in human malignant melanomas.
    Tokita T; Maesawa C; Kimura T; Kotani K; Takahashi K; Akasaka T; Masuda T
    Int J Oncol; 2007 Mar; 30(3):689-94. PubMed ID: 17273770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biology of tumor progression in human melanocytes.
    Herlyn M; Clark WH; Rodeck U; Mancianti ML; Jambrosic J; Koprowski H
    Lab Invest; 1987 May; 56(5):461-74. PubMed ID: 3553733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
    Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
    Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.
    Ryu B; Kim DS; Deluca AM; Alani RM
    PLoS One; 2007 Jul; 2(7):e594. PubMed ID: 17611626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.
    Rius FE; Papaiz DD; Azevedo HFZ; Ayub ALP; Pessoa DO; Oliveira TF; Loureiro APM; Andrade F; Fujita A; Reis EM; Mason CE; Jasiulionis MG
    Clin Epigenetics; 2022 May; 14(1):68. PubMed ID: 35606887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and function of CD9 in melanoma cells.
    Fan J; Zhu GZ; Niles RM
    Mol Carcinog; 2010 Jan; 49(1):85-93. PubMed ID: 19777564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of lncRNAs and predicted target genes in normal mouse melanocytes and B16 cells.
    Ji K; Zhang J; Fan R; Yang S; Dong C
    Exp Dermatol; 2018 Nov; 27(11):1230-1236. PubMed ID: 30099777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
    Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
    Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.
    Mueller DW; Rehli M; Bosserhoff AK
    J Invest Dermatol; 2009 Jul; 129(7):1740-51. PubMed ID: 19212343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
    Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
    Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study.
    Loir B; Pérez Sánchez C; Ghanem G; Lozano JA; García-Borrón JC; Jiménez-Cervantes C
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1083-92. PubMed ID: 10644013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biology of normal melanocytes and melanoma cells.
    Bandarchi B; Jabbari CA; Vedadi A; Navab R
    J Clin Pathol; 2013 Aug; 66(8):644-8. PubMed ID: 23526597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression.
    Tellez CS; Davis DW; Prieto VG; Gershenwald JE; Johnson MM; McCarty MF; Bar-Eli M
    J Invest Dermatol; 2007 Feb; 127(2):387-93. PubMed ID: 16946713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
    Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
    Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
    Jiang Z; Cinti C; Taranta M; Mattioli E; Schena E; Singh S; Khurana R; Lattanzi G; Tsinoremas NF; Capobianco E
    PLoS One; 2018; 13(11):e0206686. PubMed ID: 30485296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.